Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 200

1.

A comprehensive evaluation of myocardial fibrosis in hypertrophic cardiomyopathy with cardiac magnetic resonance imaging: linking genotype with fibrotic phenotype.

Ellims AH, Iles LM, Ling LH, Chong B, Macciocca I, Slavin GS, Hare JL, Kaye DM, Marasco SF, McLean CA, James PA, du Sart D, Taylor AJ.

Eur Heart J Cardiovasc Imaging. 2014 Oct;15(10):1108-16. doi: 10.1093/ehjci/jeu077. Epub 2014 May 12.

2.

Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction.

Ellims AH, Iles LM, Ling LH, Hare JL, Kaye DM, Taylor AJ.

J Cardiovasc Magn Reson. 2012 Oct 29;14:76. doi: 10.1186/1532-429X-14-76.

3.

Myocardial fibrosis progression on cardiac magnetic resonance in hypertrophic cardiomyopathy.

Choi HM, Kim KH, Lee JM, Yoon YE, Lee SP, Park EA, Lee W, Kim YJ, Cho GY, Sohn DW, Kim HK.

Heart. 2015 Jun;101(11):870-6. doi: 10.1136/heartjnl-2014-306555. Epub 2015 Apr 20.

PMID:
25897040
4.

T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.

Ho CY, Abbasi SA, Neilan TG, Shah RV, Chen Y, Heydari B, Cirino AL, Lakdawala NK, Orav EJ, González A, López B, Díez J, Jerosch-Herold M, Kwong RY.

Circ Cardiovasc Imaging. 2013 May 1;6(3):415-22. doi: 10.1161/CIRCIMAGING.112.000333. Epub 2013 Apr 2.

5.

Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy.

Urbano-Moral JA, Rowin EJ, Maron MS, Crean A, Pandian NG.

Circ Cardiovasc Imaging. 2014 Jan;7(1):11-9. doi: 10.1161/CIRCIMAGING.113.000842. Epub 2013 Nov 25.

6.

Endogenous contrast T1rho cardiac magnetic resonance for myocardial fibrosis in hypertrophic cardiomyopathy patients.

Wang C, Zheng J, Sun J, Wang Y, Xia R, Yin Q, Chen W, Xu Z, Liao J, Zhang B, Gao F.

J Cardiol. 2015 Dec;66(6):520-6. doi: 10.1016/j.jjcc.2015.03.005. Epub 2015 May 14.

PMID:
25981868
7.

Quantification and significance of diffuse myocardial fibrosis and diastolic dysfunction in childhood hypertrophic cardiomyopathy.

Hussain T, Dragulescu A, Benson L, Yoo SJ, Meng H, Windram J, Wong D, Greiser A, Friedberg M, Mertens L, Seed M, Redington A, Grosse-Wortmann L.

Pediatr Cardiol. 2015 Jun;36(5):970-8. doi: 10.1007/s00246-015-1107-7. Epub 2015 Jan 21.

PMID:
25605038
8.

Native T1-mapping for non-contrast assessment of myocardial fibrosis in patients with hypertrophic cardiomyopathy--comparison with late enhancement quantification.

Małek ŁA, Werys K, Kłopotowski M, Śpiewak M, Miłosz-Wieczorek B, Mazurkiewicz Ł, Petryka-Mazurkiewicz J, Marczak M, Witkowski A.

Magn Reson Imaging. 2015 Jul;33(6):718-24. doi: 10.1016/j.mri.2015.04.001. Epub 2015 Apr 8.

PMID:
25863138
9.

T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study.

Hinojar R, Varma N, Child N, Goodman B, Jabbour A, Yu CY, Gebker R, Doltra A, Kelle S, Khan S, Rogers T, Arroyo Ucar E, Cummins C, Carr-White G, Nagel E, Puntmann VO.

Circ Cardiovasc Imaging. 2015 Dec;8(12). pii: e003285. doi: 10.1161/CIRCIMAGING.115.003285.

PMID:
26659373
10.

Mitral annular plane systolic excursion is an easy tool for fibrosis detection by late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy.

Doesch C, Sperb A, Sudarski S, Lossnitzer D, Rudic B, Tülümen E, Heggemann F, Schimpf R, Schoenberg SO, Borggrefe M, Papavassiliu T.

Arch Cardiovasc Dis. 2015 Jun-Jul;108(6-7):356-66. doi: 10.1016/j.acvd.2015.01.010. Epub 2015 Apr 8.

11.

Myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy.

Dass S, Suttie JJ, Piechnik SK, Ferreira VM, Holloway CJ, Banerjee R, Mahmod M, Cochlin L, Karamitsos TD, Robson MD, Watkins H, Neubauer S.

Circ Cardiovasc Imaging. 2012 Nov;5(6):726-33. doi: 10.1161/CIRCIMAGING.112.976738. Epub 2012 Oct 15.

12.

CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation.

Papavassiliu T, Germans T, Flüchter S, Doesch C, Suriyakamar A, Haghi D, Süselbeck T, Wolpert C, Dinter D, Schoenberg SO, van Rossum AC, Borggrefe M.

J Cardiovasc Magn Reson. 2009 Sep 9;11:34. doi: 10.1186/1532-429X-11-34.

13.

Increased extent of myocardial fibrosis in genotyped hypertrophic cardiomyopathy with ventricular tachyarrhythmias.

Fujita T, Konno T, Yokawa J, Masuta E, Nagata Y, Fujino N, Funada A, Hodatsu A, Kawashiri MA, Yamagishi M, Hayashi K.

J Cardiol. 2015 Jul;66(1):63-8. doi: 10.1016/j.jjcc.2014.10.002. Epub 2014 Nov 14.

14.

The current and emerging role of cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy.

Maron MS.

J Cardiovasc Transl Res. 2009 Dec;2(4):415-25. doi: 10.1007/s12265-009-9136-3. Epub 2009 Nov 7. Review.

PMID:
20560000
15.

Noninvasive assessment of myocardial fibrosis in patients with obstructive hypertrophic cardiomyopathy.

Almaas VM, Haugaa KH, Strøm EH, Scott H, Smith HJ, Dahl CP, Geiran OR, Endresen K, Aakhus S, Amlie JP, Edvardsen T.

Heart. 2014 Apr;100(8):631-8. doi: 10.1136/heartjnl-2013-304923. Epub 2013 Dec 24.

PMID:
24368281
16.

Myocardial Fibrosis in Hypertrophic Cardiomyopathy: Volumetric Assessment of Late Enhancement Provided by Cardiac Computed Tomography.

Langer C, Schaefer P, Lutz M, Eden M, Hohnhorst M, Harders H, Faber L, Jansen O, Both M, Frey N.

J Comput Assist Tomogr. 2015 Sep-Oct;39(5):797-803. doi: 10.1097/RCT.0000000000000272.

PMID:
26125299
17.

Extent of late gadolinium enhancement at right ventricular insertion points in patients with hypertrophic cardiomyopathy: relation with diastolic dysfunction.

Zhu Y, Park EA, Lee W, Kim HK, Chu A, Chung JW, Park JH.

Eur Radiol. 2015 Apr;25(4):1190-200. doi: 10.1007/s00330-014-3390-8. Epub 2015 Jan 18.

PMID:
25597022
18.

Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I.

Moon JC, Mogensen J, Elliott PM, Smith GC, Elkington AG, Prasad SK, Pennell DJ, McKenna WJ.

Heart. 2005 Aug;91(8):1036-40.

19.

Histological validation of cardiac magnetic resonance analysis of regional and diffuse interstitial myocardial fibrosis.

Iles LM, Ellims AH, Llewellyn H, Hare JL, Kaye DM, McLean CA, Taylor AJ.

Eur Heart J Cardiovasc Imaging. 2015 Jan;16(1):14-22. doi: 10.1093/ehjci/jeu182. Epub 2014 Oct 28.

20.

T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy.

aus dem Siepen F, Buss SJ, Messroghli D, Andre F, Lossnitzer D, Seitz S, Keller M, Schnabel PA, Giannitsis E, Korosoglou G, Katus HA, Steen H.

Eur Heart J Cardiovasc Imaging. 2015 Feb;16(2):210-6. doi: 10.1093/ehjci/jeu183. Epub 2014 Sep 22.

Items per page

Supplemental Content

Write to the Help Desk